These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8395713)

  • 21. Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin.
    Haas S; Wolf H; Kakkar AK; Fareed J; Encke A
    Thromb Haemost; 2005 Oct; 94(4):814-9. PubMed ID: 16270636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The home treatment of deep vein thrombosis with low molecular weight heparin, forced mobilisation and compression.
    Labas P; Ohrádka B; Vladimír J; Cambal M
    Int Angiol; 2000 Dec; 19(4):303-7. PubMed ID: 11305727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis.
    Lopaciuk S; Bielska-Falda H; Noszczyk W; Bielawiec M; Witkiewicz W; Filipecki S; Michalak J; Ciesielski L; Mackiewicz Z; Czestochowska E; Zawilska K; Cencora A
    Thromb Haemost; 1999 Jan; 81(1):26-31. PubMed ID: 9974369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial.
    Haas S; Flosbach CW
    Semin Thromb Hemost; 1993; 19 Suppl 1():164-73. PubMed ID: 8395721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low incidence of hemorrhagic complications of oral anticoagulant therapy in patients with atrial fibrillation in the daily practice of an anticoagulation clinic.
    Poli D; Antonucci E; Lombardi A; Cecchi E; Corsini I; Gensini GF; Abbate R; Prisco D
    Ital Heart J; 2003 Jan; 4(1):44-7. PubMed ID: 12690920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism.
    Schutgens RE; Esseboom EU; Snijder RJ; Haas FJ; Verzijlbergen F; Nieuwenhuis HK; Lisman T; Biesma DH
    J Lab Clin Med; 2004 Aug; 144(2):100-7. PubMed ID: 15322504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assessment of complications of major orthopedic surgery: comparison of indobufen, calcium heparin, and low molecular heparin].
    Borghi B; Bassi A; Grazia M; Feoli MA; Pignotti E
    Minerva Anestesiol; 1996 Mar; 62(3):93-100. PubMed ID: 8767154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preventive treatment of systemic embolic complications of atrial fibrillation].
    Asseman P; Bauchart JJ; Amrouni N; Lesenne M; Neuville C; Loubeyre C; Elkohen M; Thery C; Jude B
    Ann Cardiol Angeiol (Paris); 1992 Mar; 41(3):163-9. PubMed ID: 1610098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arterial embolism in thyrotoxicosis with atrial fibrillation.
    Bar-Sela S; Ehrenfeld M; Eliakim M
    Arch Intern Med; 1981 Aug; 141(9):1191-2. PubMed ID: 7259379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Atrial fibrillation. What's new in treatment and prophylaxis of embolic complications?].
    Musiał WJ
    Pol Merkur Lekarski; 1996 Nov; 1(5):351-4. PubMed ID: 9273217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis.
    Anavekar NS; Tleyjeh IM; Anavekar NS; Mirzoyev Z; Steckelberg JM; Haddad C; Khandaker MH; Wilson WR; Chandrasekaran K; Baddour LM
    Clin Infect Dis; 2007 May; 44(9):1180-6. PubMed ID: 17407036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New oral anticoagulants in the prevention of embolic complications in patients with atrial fibrillation. Polish Cardiac Society, Polish Neurological Society and Working Group on Haemostasis of the Polish Society of Haematologists and Transfusiologists consensus statement].
    Pruszczyk P; Stępińska J; Banasiak W; Członkowska A; Opolski G; Niewada M; Ponikowski P; Tendera M; Windyga J
    Kardiol Pol; 2012; 70(9):979-88. PubMed ID: 22993019
    [No Abstract]   [Full Text] [Related]  

  • 36. Peripheral arterial embolism: a prospective study of 40 consecutive cases.
    Pung LY; Mohamed SR
    Med J Malaysia; 1990 Jun; 45(2):131-5. PubMed ID: 2152017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of left atrial thrombosis by low-molecular-weight heparin. A preliminary study of 6 cases].
    Labèque JN; Laffort P; Lafitte S; Jaïs C; Coste P; Roudaut R
    Arch Mal Coeur Vaiss; 2000 Dec; 93(12):1528-33. PubMed ID: 11211448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical markers of embolic risk in patients with atrial fibrillation.
    Di Pasquale G; Urbinati S; Ribani MA; Passarelli P; Pinelli G
    G Ital Cardiol; 1994 Mar; 24(3):315-24. PubMed ID: 8063067
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation.
    Flegel KM; Hanley J
    Stroke; 1989 Aug; 20(8):1000-4. PubMed ID: 2756532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High risk of systemic embolism in hypertrophic cardiomyopathy.
    Kogure S; Yamamoto Y; Tomono S; Hasegawa A; Suzuki T; Murata K
    Jpn Heart J; 1986 Jul; 27(4):475-80. PubMed ID: 3783930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.